Earnings Review · 27 October 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-10-26 the shares closed at $322.17, +1.8% against the prior close of $316.49 (opening +0.2% from the prior close). Across the last 25 reports the shares have moved an average of +0.7% over the five sessions after the print, so the +1.8% on the day sits ahead of that average.
Did the flow confirm the move?
Underlying money flow is neutral (21-day Chaikin Money Flow -0.01, five-day price change -0.9%, as of 2026-10-23, desk flow model): no strong accumulation or distribution signature.
Give the business its due
The business itself is genuinely strong: revenue growing about 24%, net margins near 24%, a strong competitive moat, backed by a 23% return on equity.
Levels that matter
At $322.17 the shares sit 23% below the 52-week high of $416.69 and 23% above the low of $262.75 (39% of the way up the range). The 50-day average is $318.83, below the price. The 200-day average is $327.23, above the price.
The valuation lens
The shares trade close to our fair-value estimate (+3% margin of safety): fairly priced, little cushion for a miss. Fair value lands near $332 against a $322.17 share price, a margin of safety of about 3%. The trailing multiple sits around 65 times earnings, which only makes sense if the growth holds.
The ethical lens, our differentiator
Screens compliant (both standards agree). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.
